4.7 Article

Obesity and Bronchodilator Response in Black and Hispanic Children and Adolescents With Asthma

期刊

CHEST
卷 147, 期 6, 页码 1591-1598

出版社

ELSEVIER
DOI: 10.1378/chest.14-2689

关键词

-

资金

  1. National Institutes of Health [R01-ES015794, U19-AI077439, R01-HL088133, R01-HL078885, R01-HL104608]
  2. National Institute on Minority Health and Health Disparities of the National Institutes of Health [P60-MD006902]
  3. National Center for Research Resources [M01-RR00188]
  4. Flight Attendant Medical Research Institute (FAMRI)
  5. Sandler Foundation
  6. RWJF Amos Medical Faculty Development Award
  7. American Asthma Foundation
  8. Ernest S. Bazley Grant
  9. National Institute of General Medical Sciences [T32-GM007546]
  10. National Institute of Child Health and Human Development [T32-GM00754635]

向作者/读者索取更多资源

BACKGROUND: Obesity is associated with poor asthma control, increased asthma morbidity, and decreased response to inhaled corticosteroids. We hypothesized that obesity would be associated with decreased bronchodilator responsiveness in children and adolescents with asthma. In addition, we hypothesized that subjects who were obese and unresponsive to bronchodilator would have worse asthma control and would require more asthma controller medications. METHODS: In the Study of African Americans, Asthma, Genes, and Environments (SAGE II) and the Genes-environments and Admixture in Latino Americans (GALA II) study, two identical, parallel, case-control studies of asthma, we examined the association between obesity and bronchodilator response in 2,963 black and Latino subjects enrolled from 2008 to 2013 using multivariable logistic regression. Using bronchodilator responsiveness, we compared asthma symptoms, controller medication usage, and asthma exacerbations between nonobese (< 95th% BMI) and obese (>= 95th% BMI) subjects. RESULTS: The odds of being bronchodilator unresponsive were 24% (OR, 1.24; 95% CI, 1.03-1.49) higher among obese children and adolescents compared with their not obese counterparts aft er adjustment for age, race/ethnicity, sex, recruitment site, baseline lung function (FEV1/FVC), and controller medication. Bronchodilator-unresponsive obese subjects were more likely to report wheezing (OR, 1.38; 95% CI, 1.13-1.70), being awakened at night (OR, 1.34; 95% CI, 1.09-1.65), using leukotriene receptor inhibitors (OR, 1.33; 95% CI, 1.05-1.70), and using inhaled corticosteroid with long-acting beta(2)-agonist (OR, 1.37; 95% CI, 1.05-1.78) than were their nonobese counterpart. These associations were not seen in the bronchodilator-responsive group. CONCLUSIONS: Obesity is associated with bronchodilator unresponsiveness among black and Latino children and adolescents with asthma. The findings on obesity and bronchodilator unresponsiveness represent a unique opportunity to identify factors affecting asthma control in blacks and Latinos.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据